Early-Stage Renal Cell Carcinoma Locoregional Therapies: Current Approaches and Future Directions
Open Access
- 1 January 2024
- journal article
- review article
- Published by SAGE Publications in Clinical Medicine Insights: Oncology
- Vol. 18
Abstract
Renal cell carcinoma (RCC) is the most common primary renal malignancy. Prevalence of RCC in developed countries has slowly increased. Although partial or total nephrectomy has been the first-line treatment for early-stage RCC, improved or similar safety and treatment outcomes with locoregional therapies have challenged this paradigm. In this review, we explore locoregional techniques for early-stage RCC, including radiofrequency ablation, cryoablation, and microwave ablation with a focus on procedural technique, patient selection, and safety/treatment outcomes. Furthermore, we discuss future advances and novel techniques, including radiomics, combination therapy, high-intensity focused ultrasound, and catheter-directed techniques.Keywords
This publication has 52 references indexed in Scilit:
- Role of renal mass biopsy for diagnosis and management: Review of current trends and future directionsCancer Cytopathology, 2023
- Cost-effectiveness of minimally invasive partial nephrectomy and percutaneous cryoablation for cT1a renal cell carcinomaEuropean Radiology, 2022
- RESIRT: A Phase 1 Study of Selective Internal Radiation Therapy Using Yttrium-90 Resin Microspheres in Patients With Primary Renal Cell CarcinomaClinical Genitourinary Cancer, 2022
- Trans-arterial embolization of renal cell carcinoma: a systematic review and meta-analysisAbdominal Radiology, 2022
- The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomyEuropean Journal of Surgical Oncology, 2022
- Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?Current Oncology Reports, 2021
- A multicenter 10-year oncologic outcome of ultrasound-guided percutaneous microwave ablation of clinical T1 renal cell carcinoma: will it stand the test of time?European Radiology, 2021
- Cryoablation of renal tumors: long-term follow-up from a multicenter experienceAbdominal Radiology, 2021
- Percutaneous Cryoablation versus Robot-Assisted Partial Nephrectomy of Renal T1A Tumors: a Single-Center Retrospective Cost-Effectiveness AnalysisCardioVascular and Interventional Radiology, 2021
- Role of Angio-Embolization for Renal Cell CarcinomaCurrent Urology Reports, 2018